Document:

Asia Leechdom Holding Corporation: Exhibit 10.22 - Filed by
   newsfilecorp.com

Exhibit 10.22

Tianjin Boai Pharmaceutical Co., Ltd.  

Contract of Purchases and Sales of Products
 

	Supplier: Tianjin Boai Pharmaceutical Co., Ltd. 	Contract No.: 
	Acquirer: Hebei Dongsheng Yinghua Medicine Co, Ltd.
    	Signing Place: 
	  	Signing Date: Jan 4, 2010

1. Category, Specification, Quantity and Price 

	  	Product 	  	  	  	Subtotal 
	         Product Name 	  	Unit 	Quantity 	Unit Price 	  
	  	Standard 	  	  	  	Amount 
	
    Semifluid Extract of 
	  	  	  	  	  
	
    Motherwort
      Compound  
	15g×6 	Box 	5,000 	670 	3,350,000 
	
    Semifluid Extract of 
	  	  	  	  	  
	
    Motherwort
      Compound 
	60g 	Box 	4,000 	600 	2,400,000 
	
    Semifluid Extract for 
	  	  	  	  	  
	
    Clearing away the 
	  	  	  	  	  
	
    Lung-heat and 
	60g 	Box 	6,000 	500 	3,000,000 
	
    Reducing
      Internal-heat 
	  	  	  	  	  
	
    Semifluid Extract for 
	  	  	  	  	  
	
    nourishing Yin and 
	  	  	  	  	  
	
    Clearing away the 
	10ml×8 	Box 	5,000 	1,050 	5,250,000 
	
    Lung-heat
	  	  	  	  	  
	
    Semifluid Extract for 
	  	  	  	  	  
	
    Tonifying Qi and 
	60g 	Box 	6,000 	550 	3,300,000 
	
    Relieving
      Constipation 
	  	  	  	  	  
	
Total amount in RMB (Capitalized): Thirteen Million Three
Hundred Thousand 

    

2. Quality Requirements: the quality of products should be in
line with the Chinese Pharmacopoeia and the Standards of
Pharmaceuticals Industry. 

3. Place of Delivery: warehouse of the acquirer. 

4. Time Limit of Delivery and Receipt: within 30 days from the
order date. 

5. Transportation Mode, Arrival Place and Freight Payer: the
Supplier shall delivery the products to the Acquirer in _____days at the arrival
place of the Acquirer’s warehouse , the Acquirer shall be
responsible for the freight and the unloading charges after arrival of the
goods. 

6. Ways of Check and Acceptance: after the receipt of the
products by the Acquirer, they could raise an objection to the Supplier in
writing within 7 days started from the receipt if any of the category,
specification, quantity and quality does not match the contract requirements,
otherwise the products would be deemed to be in accordance with the standards.
Similarly the Supplier should make the response with handling suggestions within
7 days started from receiving the written objection from the Acquirer, otherwise
they should be considered as acquiescence with the objection. 

7. Settlement Form and Time Limit: Wire Transfer on a
Monthly Basis 

8. Default Responsibility: if there is overdue payment by the
Acquirer, they should pay 10% of the overdue part as liquidated damages. 

9. Solutions of Contractual Dispute: if any dispute occurs, the
Supplier and the Acquire should resolve the dispute through consultation, when
no results come to the end, the dispute would be applied to an arbitral
authority in the Supplier’s area for arbitration. 

10. Other Terms Appointed: the Supplier promises to provide
other products on the basic of factory prices. 

11. Notice: The Contract is in quadruplication, every piece is
legally of equal effect after being signed and sealed by the Parties. 

	the Supplier: 	the Acquirer: 
	
    (Special Contract Seal of Tianjin Boai 
	
    (Special Contract Seal of Hebei 

	
    Pharmaceutical Co., Ltd.) 
	
    Dongsheng Yinghua Medicine Co, Ltd.)
  

	
    Company Name: 
	
    Company Name: 

	
    Tianjin Boai Pharmaceutical Co., Ltd. 
	
     

	
    Company Address: 
	
    Company Address: 

	
    No. 4, Ronghua Road, Nanhe Town, 
	
     

	
    Xiqing District, Tianjin 
	
     

	
    Signatory Representative: 
	
    Signatory Representative: 

	
    Opening Bank: 
	
    Opening Bank: 

	
    Tianjin Binhai Rural Commercial Bank 
	
     

	
    Co., Ltd., Ningfa Subbranch 
	
     

	
    Opening Account No.: 
	
    Opening Account No.: 

	
    9101101000010000004209 
	
     

	
    Tax No.: 12011730358629 
	
    Tax No.: 

	
    Telephone: 022-27610853 
	
    Telephone: 

	
    Fax: 022-27610853 
	
    Fax: 

	
    Pose Code:
    
	
    Pose Code: 

Duration of the Contract: from Jan. 4 2010 to Jan. 3,
2011 .Asia Leechdom Holding COrporation: Exhibit 10.23 - Filed by newsfilecorp.com

Exhibit 10.23

Equity Transfer Agreement 

Keytech Holding Inc. (the acquirer, herein referred to as the
“Party A”) and the original shareholder Xuecheng Xia with Tianjin Boai
Pharmaceutical Co., Ltd. (the acquiree, herein referred to as the “Party B”)
have made this Equity Transfer Agreement. 

Party A: Keytech Holding Inc.

Address: 45 Old Millstone Drive, Unit #6, East Windsor, NJ 08520 
Legal
Representative: Chenghai Du 
Title: Chairman 
Nationality: Dominica 

Party B: Xuecheng Xia (shareholder of
Tianjin Boai Pharmaceutical Co., Ltd.) 
Nationality: P.R. China 
ID:
120103560326264 

	1. 	
      Party B shall transfer her equity of Tianjin Boai
      Pharmaceutical Co., Ltd., which is equal to 81.4%, to Party A and furnish
      all legal documents for this equity transfer. 

	2. 	
      Party A shall pay RMB 7 million to Party B for acquiring
      Party B’s equity. 

	3. 	
      Party A shall make the payment in a single transaction to
      Party B within the six months since this agreement is made. Party A shall
      transfer the payment to Party B’s account in Bank of China. The payment is
      denominated in U.S. Dollars according to the exchange rate published by
      the State Administration of Foreign Exchange of P.R. China on the payment
      date. 

	4. 	
      (1) Party A shall pay for the acquired equity to Party B
      in full amount in time according to this agreement. 

		
      (2) Party A shall seal the acquisition and provide the
      following documents for the incorporation of foreign-funded enterprise.
      

	 	a. 	Agreement and Regulations of the foreign-funded enterprise after
      equity transfer. 
	 	b. 	Party A’s incorporation document and credit standing document. 
	 	c. 	Party A’s business operation statement. 
	 	d. 	Party A’s business license copy. 

	5. 	
      (1) Party B shall provide the resolution to equity
      transfer agreement to Party A. 

		
      (2) Party B shall handle the transferring of equity.
    

		
      (3) Party B shall provide audited financial statements of
      the past three years to Party A. 

		
      (4) Party B shall provide business operation statement.
      

		
      (5) Party B shall provide the application for legally
      changing and incorporating the foreign-funded enterprise.
  

(6) Party B shall provide business license copy. 

6. (1) Party A shall pay the late fee of 1% of the total
payment every month if Party B does not receive the full amount of payment in 15
days after the agreed payment date referred to the terms in 3. Party A shall pay
the late fee of 3% of the total payment every month and any loses if Party B
does not receive the full amount of payment in three months after the agreed
payment date referred to the terms in 3. If any party failed to fulfill and
execute this Agreement, the liable party should make compensation to the other.

(2) Party A and Party B shall negotiate for settlement when
default or misinterpretation in connection to this Agreement happens. If failed
to negotiate for settlement, Party A and Party B could submit their dispute for
binding arbitration to Party B’s local court. 

7. This agreement is governed by the laws of P.R. China. 

8. (1) This Agreement is written in Chinese and English. The
final interpretation of the Chinese Agreement shall prevail. 

(2) The changing and supplementing of this Agreement shall be
agreed by both parties and have the same legal enforcement as this Agreement.

(3) Matters not provided for in this Agreement, by “The
Business Laws of Foreign Joint Ventures of P.R. China”, shall be decided through
mutual consultation.

(4) Each Party has a copy of this Agreement. 

Party A: 

Legal Representative Signature: 

Party B: Xuecheng Xia (shareholder of Tianjin Boai
Pharmaceutical Co., Ltd.) 

Signature: 

Date: July 5, 2007Asia Leechdom Holding Corporation: Exhibit 10.24 - Filed by newsfilecorp.com

Exhibit 10.24

Equity Transfer Agreement 

Keytech Holding Inc. (the acquirer, herein referred to as the
“Party A”) and the original shareholder Yansheng Wang with Tianjin Boai
Pharmaceutical Co., Ltd. (the acquiree, herein referred to as the “Party B”)
have made this Equity Transfer Agreement. 

Party A: Keytech Holding Inc. 
Address: 45 Old Millstone
Drive, Unit #6, East Windsor, NJ 08520 
Legal Representative: Chenghai Du

Title: Chairman 
Nationality: Dominica 

Party B: Yansheng Wang (shareholder of Tianjin Boai
Pharmaceutical Co., Ltd.) 
Nationality: P.R. China 
ID: 120103551010111

	1. 	
      Party B shall transfer his equity of Tianjin Boai
      Pharmaceutical Co., Ltd., which is equal to 18.6%, to Party A and furnish
      all legal documents for this equity transfer. 

	2. 	
      Party A shall pay RMB 1.6 million to Party B for
      acquiring Party B’s equity. 

	3. 	
      Party A shall make the payment in a single transaction to
      Party B within the six months since this agreement is made. Party A shall
      transfer the payment to Party B’s account in Bank of China. The payment is
      denominated in U.S. Dollars according to the exchange rate published by
      the State Administration of Foreign Exchange of P.R. China on the payment
      date. 

	4. 	
      (1) Party A shall pay for the acquired equity to Party B
      in full amount in time according to this agreement. 

		
      (2) Party A shall seal the acquisition and provide the
      following documents for the incorporation of foreign-funded enterprise.
      

	 	a. 	
      Agreement and Regulations of the foreign-funded
      enterprise after equity transfer. 

	 	b. 	
      Party A’s incorporation document and credit standing
      document. 

	 	c. 	
      Party A’s business operation statement. 

	 	d. 	
      Party A’s business license copy. 

	5. 	
      (1) Party B shall provide the resolution to equity
      transfer agreement to Party A. 

		
      (2) Party B shall handle the transferring of equity.
    

		
      (3) Party B shall provide audited financial statements of
      the past three years to Party A. 

		
      (4) Party B shall provide business operation statement.
      

		
      (5) Party B shall provide the application for legally
      changing and incorporating the foreign-funded enterprise.
  

(6) Party B shall provide business
license copy. 

6. (1) Party A shall pay the late fee of 1% of the total
payment every month if Party B does not receive the full amount of payment in 15
days after the agreed payment date referred to the terms in 3. Party A shall pay
the late fee of 3% of the total payment every month and any loses if Party B
does not receive the full amount of payment in three months after the agreed
payment date referred to the terms in 3. If any party failed to fulfill and
execute this Agreement, the liable party should make compensation to the other.

(2) Party A and Party B shall negotiate for settlement when
default or misinterpretation in connection to this Agreement happens. If failed
to negotiate for settlement, Party A and Party B could submit their dispute for
binding arbitration to Party B’s local court. 

7. This agreement is governed by the laws of P.R. China. 

8. (1) This Agreement is written in Chinese and English. The
final interpretation of the Chinese Agreement shall prevail. 

(2) The changing and supplementing of this Agreement shall be
agreed by both parties and have the same legal enforcement as this Agreement.

(3) Matters not provided for in this Agreement, by “The
Business Laws of Foreign Joint Ventures of P.R. China”, shall be decided through
mutual consultation.

(4) Each Party has a copy of this Agreement. 

Party A: 

Legal Representative Signature: 

Party B: Yansheng Wang (shareholder of Tianjin Boai
Pharmaceutical Co., Ltd.) 

Signature: 

Date: July 5, 2007

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00184-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00184-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00184-of-00352.parquet"}]]